Jomed swaps ceramic for polymer stent coating
This article was originally published in Clinica
Executive Summary
Jomed's German arm, Jomed GmbH, has licensed a new polymer coating for its drug-coated stent development work, shortly after giving up on a ceramic alternative. The Medi-Coat drug delivery coating provided by STS Biopolymers offers controlled release of drugs over a period of days, weeks or months.
You may also be interested in...
Sanofi Prepares Pulmonologists As Dupixent Nears COPD Finishing Line
The French drugmaker has identified education as a key challenge ahead of its June action date for the huge-selling IL4/IL-13 inhibitor in the lung condition. An approval would make it the first biologic for the disease.
Global Pharma Guidance Tracker – March 2024
Stay up to date on regulatory guidelines from around the world with the Pink Sheet's Guidance Tracker. The complete Global Pharma Guidance Tracker, with sortable and searchable listings going back to 2014, is available online.
EU Stakeholders Devise Six-Point Plan To Improve Cross-Border Clinical Trials
Sponsors need guidance on ethics requirements and clarity around national regulations to conduct cross-border clinical trials in the EU, a multi-stakeholder forum says.